16:37 10/29 UTC — Mixed
The market presents a mixed picture as sharp earnings-induced declines in GOOGL and NOW test tech sector sentiment. Benchmark ETFs like SPY and QQQ are actively fighting to hold VWAP support amid strong intraday dip-buying attempts. Investors remain cautious as all eyes turn toward Amazon's earnings report after the market close.
Markets are experiencing heightened intraday volatility driven by harsh post-earnings reactions in key tech names like GOOGL and NOW. While major benchmark ETFs (SPY and QQQ) are attempting technical bounces off VWAP levels, tech sentiment remains under pressure due to free cash flow concerns and AI capex spending. High-profile M&A announcements, such as DoorDash acquiring Instacart for $17B, provide specific stock catalysts amidst broader earnings anxiety.
Outlook
Mixed · Intraday (Medium)
Base — Likely
Indices trade in a tight, volatile range around intraday VWAP as traders position ahead of Amazon's after-hours earnings release.
Bear — Possible
Continued liquidation in high-volume tech stocks triggers a broader selloff below key SPY 768.50 support.
Bull — Possible
VIX compression and strong buying off support levels ignite a late-day short squeeze across mega-cap tech.
Hot tickers
- GOOGL Bearish — Stock plunged over 12% following Q3 results due to a massive free cash flow deficit (-$9.1B) despite strong cloud growth.
- IOVA Bearish — Heavy selloff taking shares below $9 following disappointing trial ORR metrics, triggering aggressive shorting.
- NOW Bearish — Shares dropped 25% with institutional selling keeping the price locked down near intraday lows.
- AMZN Neutral — Extremely volatile commentary and positioning ahead of tonight's crucial Q3 earnings report.
- META Bullish — Stock broke above its 200 SMA with dip-buyers active and Bill Ackman noting the stock is heavily undervalued.
Themes
- Tech Earnings Cash Flow Scrutiny
- Intraday Index Volatility at VWAP Support
- Mega-Cap M&A Deal Activity
Risks
- Severe post-earnings drops in mega-cap and software tech names (GOOGL down 12%+, NOW down 25%)
- Heightened cash burn and negative free cash flow metrics among hyperscalers
- Sharp biotech volatility triggered by clinical trial/ORR data misses
Get digest by email Open live dashboard All digests About FC Global